Trial · NCT01708590
Participant flow42
How many started, completed or left each group, period by period.
21 to 40 of 42
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Induction Phase | NOT COMPLETED | Withdrawl Phase: 210mg Brodalumab Q2W | 0 | |
| Withdrawal Phase | STARTED | Induction Phase: 210 mg Brodalumab | 0 | |
| Withdrawal Phase | STARTED | Induction Phase: 140 mg Brodalumab | 0 | |
| Withdrawal Phase | STARTED | Induction Phase: Placebo | 0 | |
| Withdrawal Phase | STARTED | Withdrawal Phase: Placebo (140mg) | 59 | |
| Withdrawal Phase | STARTED | Withdrawal Phase: 140mg Brodalumab Q2W | 57 | |
| Withdrawal Phase | STARTED | Withdrawal Phase: Placebo (210mg) | 84 | |
| Withdrawal Phase | STARTED | Withdrawl Phase: 210mg Brodalumab Q2W | 83 | |
| Withdrawal Phase | COMPLETED | Induction Phase: 210 mg Brodalumab | 0 | |
| Withdrawal Phase | COMPLETED | Induction Phase: 140 mg Brodalumab | 0 | |
| Withdrawal Phase | COMPLETED | Induction Phase: Placebo | 0 | |
| Withdrawal Phase | COMPLETED | Withdrawal Phase: Placebo (140mg) | 6 | |
| Withdrawal Phase | COMPLETED | Withdrawal Phase: 140mg Brodalumab Q2W | 45 | |
| Withdrawal Phase | COMPLETED | Withdrawal Phase: Placebo (210mg) | 2 | |
| Withdrawal Phase | COMPLETED | Withdrawl Phase: 210mg Brodalumab Q2W | 74 | |
| Withdrawal Phase | NOT COMPLETED | Induction Phase: 210 mg Brodalumab | 0 | |
| Withdrawal Phase | NOT COMPLETED | Induction Phase: 140 mg Brodalumab | 0 | |
| Withdrawal Phase | NOT COMPLETED | Induction Phase: Placebo | 0 | |
| Withdrawal Phase | NOT COMPLETED | Withdrawal Phase: Placebo (140mg) | 53 | |
| Withdrawal Phase | NOT COMPLETED | Withdrawal Phase: 140mg Brodalumab Q2W | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01708590/flow?page=2